CS logo
small CS logo
Instituto Jalisciense de Investigacion en Diabetes y Obesida

Guadalajara, Jalisco, Mexico
Doctor in Guadalajara
Av. José María Morelos 1952, Ladrón de Guevara, Ladron De Guevara, 44600 Guadalajara, Jal.

About Instituto Jalisciense de Investigacion en Diabetes y Obesida


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
5
Pfizer
2
Boehringer Ingelheim
1
Gilead Sciences
1
Immunic AG
1
Total Rows: 5

Clinical Trials at Instituto Jalisciense de Investigacion en Diabetes y Obesida


During the past decade, Instituto Jalisciense de Investigacion en Diabetes y Obesida conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000011112233110000000000110022Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
2012-06-01
2013-10-01
Completed
442
RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
2015-11-05
2019-03-31
Completed
7,797

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Immunic AG" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 5Eli Lilly and Company: 5Pfizer: 2Pfizer: 2Boehringer Ingelheim: 1Boehringer Ingelheim: 1Gilead Sciences: 1Gilead Sciences: 1Immunic AG: 1Immunic AG: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Instituto Jalisciense de Investigacion en Diabetes y Obesida


According to Clinical.Site data, the most researched conditions in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are "Type 2 Diabetes Mellitus" (3 trials), "COVID-19" (2 trials), "Type 2 Diabetes" (2 trials), "Multiple Sclerosis" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" in a lesser frequency.

Clinical Trials Intervention Types at Instituto Jalisciense de Investigacion en Diabetes y Obesida


Most popular intervention types in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are "Drug" (9 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tirzepatide" (5 trials), "PF-07321332" (2 trials), "Placebo" (2 trials), "Ritonavir" (2 trials) and "Diet" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto Jalisciense de Investigacion en Diabetes y Obesida


The vast majority of trials in "Instituto Jalisciense de Investigacion en Diabetes y Obesida" are 10 trials for "All" genders.

Clinical Trials Status at Instituto Jalisciense de Investigacion en Diabetes y Obesida


Currently, there are NaN active trials in "Instituto Jalisciense de Investigacion en Diabetes y Obesida". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Instituto Jalisciense de Investigacion en Diabetes y Obesida, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Jalisciense de Investigacion en Diabetes y Obesida, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1